NEURONETICS INC (STIM)       5.8  -0.03 (-0.51%)

5.8  -0.03 (-0.51%)

US64131A1051 - Common Stock - After market: 5.87 +0.07 (+1.21%)

NEURONETICS INC5.8

NASDAQ:STIM (1/27/2023, 7:00:00 PM)-0.03 (-0.51%)

After market: 5.87 +0.07 (+1.21%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Health Care Equipment & Supplies

Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend

Overview
Earnings (Last) 11-08 2022-11-08/bmo Earnings (Next) 03-06 2023-03-06
Ins Owners 8.43% Inst Owners 63.64%
Market Cap 157.88M Shares 27.22M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 82
IPO 06-28 2018-06-28

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

STIM Daily chart

Company Profile

Neuronetics, Inc. commercial stage medical technology company, which engages in the designing, developing and marketing products for the patients suffering from psychiatric disorders. The company is headquartered in Malvern, Pennsylvania and currently employs 198 full-time employees. The company went IPO on 2018-06-28. The firm is focused on designing, developing, and marketing products for patients who suffer from neurohealth disorders. Its commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The NeuroStar Advanced Therapy System is used to treat adult patients with major depressive disorder (MDD). The firm intends to continue to pursue development of its NeuroStar Advanced Therapy System for additional indications. The firm sells its NeuroStar Advanced Therapy System and recurring treatment sessions in the United States. Its primary focus is on selling to psychiatrists, with primary care physicians and pain management specialists.

Company Info

NEURONETICS INC

31 General Warren Blvd.

Malvern PENNSYLVANIA 19355

P: 16106404202.0

CEO: Keith J. Sullivan

Employees: 198

Website: https://neurostar.com/neuronetics/

STIM News

News Image9 days ago - Seeking AlphaSTIM stock gains on six-year deal with Greenbrook for depression therapy (NASDAQ:STIM)

Neuronetics, Inc. (STIM) and Canada-based mental care provider Greenbrook TMS (GBNH) announced a six-year deal on Thursday for TMS devices. Read the full story here.

News Image9 days ago - NeuroneticsNeuronetics and Greenbrook TMS Announce Six Year Exclusive Partnership

MALVERN, Pa. and TORONTO, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on...

News Image9 days ago - NeuroneticsNeuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Jan. 18, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing,...

News Image11 days ago - NeuroneticsNeuronetics Announces Data Confirming Efficacy in Treating Anxious Depression with NeuroStar® Advanced Therapy for Mental Health

Peer-reviewed publication shows NeuroStar TMS as an effective non-drug treatment for depression with comorbid anxiety

News Image11 days ago - NeuroneticsNeuronetics Announces Data Confirming Efficacy in Treating Anxious Depression with NeuroStar® Advanced Therapy for Mental Health

Peer-reviewed publication shows NeuroStar TMS as an effective non-drug treatment for depression with comorbid anxiety...

News Image18 days ago - NeuroneticsNeuronetics Settles Litigation Against BrainsWay

MALVERN, Pa., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing,...

STIM Twits

Here you can normally see the latest stock twits on STIM, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example